NO984198L - FremgangsmÕte for behandling av aggresjon - Google Patents

FremgangsmÕte for behandling av aggresjon

Info

Publication number
NO984198L
NO984198L NO984198A NO984198A NO984198L NO 984198 L NO984198 L NO 984198L NO 984198 A NO984198 A NO 984198A NO 984198 A NO984198 A NO 984198A NO 984198 L NO984198 L NO 984198L
Authority
NO
Norway
Prior art keywords
aggression
procedure
treatment
olanzapine
administering
Prior art date
Application number
NO984198A
Other languages
English (en)
Other versions
NO984198D0 (no
NO323579B1 (no
Inventor
Jr Charles M Beasley
Pierre V Tran
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO984198D0 publication Critical patent/NO984198D0/no
Publication of NO984198L publication Critical patent/NO984198L/no
Publication of NO323579B1 publication Critical patent/NO323579B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Developing Agents For Electrophotography (AREA)
NO19984198A 1996-03-11 1998-09-11 Anvendelse av olanzapin for fremstilling av et legemiddel for behandling av ekstrem aggresjon NO323579B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1312796P 1996-03-11 1996-03-11
PCT/US1996/019573 WO1997033584A1 (en) 1996-03-11 1996-12-04 Method for treating excessive aggression

Publications (3)

Publication Number Publication Date
NO984198D0 NO984198D0 (no) 1998-09-11
NO984198L true NO984198L (no) 1998-11-02
NO323579B1 NO323579B1 (no) 2007-06-11

Family

ID=21758447

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19984198A NO323579B1 (no) 1996-03-11 1998-09-11 Anvendelse av olanzapin for fremstilling av et legemiddel for behandling av ekstrem aggresjon

Country Status (22)

Country Link
EP (1) EP0900085B1 (no)
JP (1) JP2000506858A (no)
KR (1) KR19990087716A (no)
CN (1) CN1124847C (no)
AT (1) ATE306269T1 (no)
AU (1) AU719517B2 (no)
BR (1) BR9612549A (no)
CA (1) CA2248753C (no)
CZ (1) CZ296579B6 (no)
DE (1) DE69635282T2 (no)
DK (1) DK0900085T3 (no)
EA (1) EA000741B1 (no)
ES (1) ES2249789T3 (no)
HU (1) HUP9903685A3 (no)
IL (1) IL126157A (no)
NO (1) NO323579B1 (no)
NZ (1) NZ325035A (no)
PL (1) PL186975B1 (no)
RO (1) RO117347B1 (no)
TR (1) TR199801799T2 (no)
UA (1) UA57727C2 (no)
WO (1) WO1997033584A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6174882B1 (en) 1998-11-23 2001-01-16 Sepracor Inc. 2-hydroxymethylolanzapine compositions and methods
CA2351718A1 (en) 1998-11-23 2000-06-02 Sepracor Inc. Desmethylolanzapine compositions and methods
WO2000030649A1 (en) * 1998-11-23 2000-06-02 Sepracor Inc. Pharmaceutical compositions containing olanzapine-n-oxide

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4595535A (en) * 1983-06-06 1986-06-17 Ciba-Geigy Corporation Diazacycloalkyl-1,2,4-triazolo[2,3-c][1,3]benzodiazepines useful as neuroleptic and/or antihistaminic agents
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
GB9009229D0 (en) * 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
US5605897A (en) * 1991-04-23 1997-02-25 Eli Lilly And Company 2-methyl-thieno-benzodiazepine
JP3274579B2 (ja) * 1995-01-12 2002-04-15 住友製薬株式会社 脳血管障害に伴う精神症候治療剤
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
US5637584A (en) * 1995-03-24 1997-06-10 Eli Lilly And Company Solvate of olanzapine
US5631250A (en) * 1995-03-24 1997-05-20 Eli Lilly And Company Process and solvate of 2-methyl-thieno-benzodiazepine
ATE220550T1 (de) * 1995-05-30 2002-08-15 Lilly Co Eli Verfahren zur behandlung von wahrnehmungsstörungen

Also Published As

Publication number Publication date
CN1213969A (zh) 1999-04-14
DK0900085T3 (da) 2006-01-30
EP0900085B1 (en) 2005-10-12
IL126157A0 (en) 1999-05-09
RO117347B1 (ro) 2002-02-28
TR199801799T2 (xx) 1999-01-18
EA000741B1 (ru) 2000-02-28
CA2248753A1 (en) 1997-09-18
IL126157A (en) 2002-09-12
AU719517B2 (en) 2000-05-11
KR19990087716A (ko) 1999-12-27
NO984198D0 (no) 1998-09-11
ATE306269T1 (de) 2005-10-15
HUP9903685A3 (en) 2001-12-28
CZ290598A3 (cs) 1999-09-15
BR9612549A (pt) 1999-07-20
PL328949A1 (en) 1999-03-01
AU1284697A (en) 1997-10-01
CA2248753C (en) 2008-11-18
CZ296579B6 (cs) 2006-04-12
PL186975B1 (pl) 2004-04-30
HUP9903685A2 (hu) 2000-03-28
UA57727C2 (uk) 2003-07-15
EP0900085A1 (en) 1999-03-10
JP2000506858A (ja) 2000-06-06
EA199800822A1 (ru) 1999-02-25
ES2249789T3 (es) 2006-04-01
CN1124847C (zh) 2003-10-22
DE69635282T2 (de) 2006-04-20
WO1997033584A1 (en) 1997-09-18
NZ325035A (en) 2001-06-29
DE69635282D1 (de) 2006-02-23
NO323579B1 (no) 2007-06-11
EP0900085A4 (en) 2000-12-13

Similar Documents

Publication Publication Date Title
EP0831832A4 (en) METHODS FOR CONTROLLING INFECTIOUS DISEASES USING DICATIONIC BIS-BENZIMIDAZOLES
EA200100572A1 (ru) Способ применения ингибитора циклооксигеназы-2 и одного или нескольких противоопухолевых лекарственных средств в качестве комбинированного способа лечебного воздействия при лечении неоплазии
DE69616376D1 (de) Verwendung von Tiagabin zur Behandlung von Schlafstörungen
DE69635708D1 (de) Tetrandrin zur behandlung von augenentzündungen
DE69729004D1 (de) Photodynamische therapie zur behandlung von osteosrthritis
EA199800866A1 (ru) Способ снятия боли
ATA901396A (de) Verwendung von melatonin zur behandlung von an medikamentensucht leidenden patienten
NO982582D0 (no) FremgangsmÕte for behandling av smerte
ATE251462T1 (de) Verfahren zur behandlung von narbengewebe
DE69910425D1 (de) Neue therapeutische verwendung von nicergoline
NO984198L (no) FremgangsmÕte for behandling av aggresjon
NO984189L (no) FremgangsmÕte for behandling av bipolar forstyrrelse
NO984196L (no) FremgangsmÕte for behandling av stoffmisbruk
NO984197D0 (no) Fremgangsmåte for behandling av autisme
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin
EA199800818A1 (ru) Способ лечения бессонницы
ATE291434T1 (de) Verwendung von angiotensin zur behandlung von krebsmetastasierung
ATE225181T1 (de) Verwendung von heparinen niedrigeren molekulargewichtes zur behandlung von hirnödemen
DE3585312D1 (de) Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a-hexahydro-4h-pyrido(1,2-a)pyrimidin-3-carboxamid zur vorbeugung und behandlung von gastrointestinalschaeden.
EA199800820A1 (ru) Способ лечения злоупотребления лекарственными средствами
NO985325L (no) Anvendelse av substituert azaspiran ved behandling av astma
UA25399A (uk) Спосіб лікуваhhя хворих гломерулоhефритом